Clinical Trial Update: LANDMARK Trial: a Randomised Controlled Trial of Myval THV [NA]

View source ↗

Summary

LANDMARK trial is a randomized controlled trial evaluating the Myval transcatheter heart valve for aortic valve stenosis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• Myval THV

Snippet

Sponsor: Meril Life Sciences Pvt. Ltd. | Conditions: Aortic Valve Stenosis | NA | Status: RECRUITING